Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5 by Single Intravitreal Injection in Patients With Wet Age-Related Macular Degeneration

NCT00722384 is registered in ClinicalTrials.gov with OPKO Health, Inc. as lead sponsor.

NCT NCT00722384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00722384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5 by Single Intravitreal Injection in Patients With Wet Age-Related Macular Degeneration
Lead sponsor
OPKO Health, Inc.
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2004
Completion date
December 31, 2007
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration